Recruiting Lung Cancer Studies in Spokane
About Lung Cancer Clinical Trials in Spokane
Lung cancer is the leading cause of cancer death worldwide, starting in the cells of the lungs. The two main types are non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). Treatments include surgery, chemotherapy, radiation, immunotherapy, and targeted drugs.
There are currently 2 lung cancer clinical trials recruiting participants in Spokane, WA. These studies are seeking a combined 255 participants. Research is being sponsored by ALX Oncology Inc., Compass Therapeutics. Clinical trial participation is free and participants receive study-related medical care at no cost.
Lung Cancer Clinical Trials in Spokane — FAQ
Are there lung cancer clinical trials in Spokane?
Yes, there are 2 lung cancer clinical trials currently recruiting in Spokane, WA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Spokane?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Spokane research site will contact you about next steps.
Are clinical trials in Spokane free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Spokane studies also compensate for your time and travel.
What lung cancer treatments are being tested?
The 2 active trials in Spokane are testing new therapies including novel drugs, biologics, and treatment approaches for lung cancer.
Data updated July 18, 2026 from ClinicalTrials.gov